Parallax Volatility Advisers’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-36,076
Closed -$1.61M – 3138
2022
Q2
$1.61M Buy
+36,076
New +$1.85M ﹤0.01% 1444
2022
Q1
– Sell
-101,817
Closed -$5.29M – 2996
2021
Q4
$5.29M Buy
+101,817
New +$5.25M ﹤0.01% 1167
2021
Q2
– Sell
-140,910
Closed -$9.18M – 3134
2021
Q1
$9.18M Buy
140,910
+74,038
+111% +$4.83M 0.01% 983
2020
Q4
$4.4M Buy
+66,872
New +$3.93M ﹤0.01% 1485
2020
Q3
– Sell
-77,306
Closed -$3.81M – 3068
2020
Q2
$3.81M Sell
77,306
-10,684
-12% -$577K ﹤0.01% 1194
2020
Q1
$4.48M Hold
87,990
– – 0.01% 907
2019
Q4
$4.85M Buy
+87,990
New +$4.77M 0.01% 919

Other funds holding EHC

Parallax Volatility Advisers's EHC Position: Q1 2022 in Review

Parallax Volatility Advisers sold out of Encompass Health (EHC) in Q1 2022, closing a stake of 7,149 shares — an estimated $371K sold.

Parallax Volatility Advisers first reported a position in EHC in Q4 2017 and held it in 10 quarters. The position peaked at $750K in Q3 2021. 406 funds tracked by Wall St. Rank hold EHC as of Q1 2022.

  • Parallax Volatility Advisers reported no remaining Encompass Health position as of Q1 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 7,149 Encompass Health shares in Q1 2022, an estimated $371K.
  • Parallax Volatility Advisers first reported a position in Encompass Health in Q4 2017 and held it in 10 quarters.
  • Parallax Volatility Advisers's Encompass Health position peaked at $750K in Q3 2021.
  • 406 funds tracked by Wall St. Rank held Encompass Health as of Q1 2022.

Based on Parallax Volatility Advisers's 13F filing for Q1 2022, filed 16 May 2022.